Rankings
▼
Calendar
ZYME Q1 2025 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27M
+170.3% YoY
Gross Profit
$27M
100.0% margin
Operating Income
-$26M
-94.5% margin
Net Income
-$23M
-83.5% margin
EPS (Diluted)
$-0.30
QoQ Revenue Growth
-12.6%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$426M
Total Liabilities
$101M
Stockholders' Equity
$325M
Cash & Equivalents
$76M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27M
$10M
+170.3%
Gross Profit
$27M
$10M
+170.3%
Operating Income
-$26M
-$38M
+32.2%
Net Income
-$23M
-$32M
+28.5%
Revenue Segments
Milestone Revenue
$14M
75%
Research Support Payments And Other Service
$4M
24%
Royalty
$202,000
1%
← FY 2025
All Quarters
Q2 2025 →